A detailed history of Voya Investment Management LLC transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 27,950 shares of EDIT stock, worth $97,266. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27,950
Previous 27,405 1.99%
Holding current value
$97,266
Previous $203,000 35.96%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$4.67 - $7.28 $2,545 - $3,967
545 Added 1.99%
27,950 $130,000
Q1 2024

May 15, 2024

SELL
$7.03 - $11.07 $38,292 - $60,298
-5,447 Reduced 16.58%
27,405 $203,000
Q4 2023

Feb 14, 2024

SELL
$6.25 - $11.11 $4,137 - $7,354
-662 Reduced 1.98%
32,852 $332,000
Q3 2023

Nov 14, 2023

BUY
$6.92 - $9.31 $41,962 - $56,455
6,064 Added 22.09%
33,514 $261,000
Q2 2023

Aug 14, 2023

BUY
$6.36 - $11.47 $5,240 - $9,451
824 Added 3.09%
27,450 $225,000
Q1 2022

May 16, 2022

SELL
$14.08 - $27.63 $4,618 - $9,062
-328 Reduced 1.22%
26,626 $506,000
Q4 2021

Feb 14, 2022

BUY
$26.55 - $40.57 $11,867 - $18,134
447 Added 1.69%
26,954 $716,000
Q3 2021

Nov 15, 2021

SELL
$39.27 - $72.94 $24,465 - $45,441
-623 Reduced 2.3%
26,507 $1.09 Million
Q2 2021

Aug 16, 2021

SELL
$31.29 - $56.64 $67,961 - $123,022
-2,172 Reduced 7.41%
27,130 $1.54 Million
Q1 2021

May 17, 2021

BUY
$39.71 - $90.58 $82,676 - $188,587
2,082 Added 7.65%
29,302 $1.23 Million
Q4 2020

Feb 16, 2021

BUY
$27.07 - $84.35 $173,248 - $539,840
6,400 Added 30.74%
27,220 $1.91 Million
Q3 2020

Nov 16, 2020

BUY
$28.06 - $37.16 $43,885 - $58,118
1,564 Added 8.12%
20,820 $584,000
Q2 2020

Aug 14, 2020

SELL
$18.5 - $34.34 $119,880 - $222,523
-6,480 Reduced 25.18%
19,256 $570,000
Q1 2020

May 15, 2020

BUY
$14.88 - $32.78 $9,195 - $20,258
618 Added 2.46%
25,736 $510,000
Q4 2019

Feb 14, 2020

BUY
$19.49 - $32.63 $110,274 - $184,620
5,658 Added 29.08%
25,118 $744,000
Q2 2019

Aug 14, 2019

BUY
$20.48 - $27.76 $9,584 - $12,991
468 Added 2.46%
19,460 $481,000
Q4 2018

Feb 14, 2019

BUY
$18.19 - $31.79 $20,791 - $36,335
1,143 Added 6.4%
18,992 $432,000
Q2 2018

Aug 14, 2018

BUY
$31.4 - $41.01 $66,254 - $86,531
2,110 Added 13.41%
17,849 $640,000
Q1 2018

May 15, 2018

BUY
$29.84 - $44.08 $10,742 - $15,868
360 Added 2.34%
15,739 $522,000
Q3 2017

Nov 14, 2017

BUY
$15.81 - $24.01 $243,141 - $369,249
15,379
15,379 $369,000

Others Institutions Holding EDIT

About Editas Medicine, Inc.


  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $239M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.